Calcipotriol monohydrate

SKU: orb1296103

Description

Calcipotriol monohydrate is a synthetic vitamin D3 analog that binds with high affinity to the vitamin D receptor. It is widely used in psoriasis research, facilitating both in vitro mechanistic studies and in vivo models of skin inflammation and keratinocyte proliferation.

Research Area

Metabolism Research

Images & Validation

−

Key Properties

−

CAS Number	147657-22-5
MW	430.62
Purity	99.95% (May vary between batches)
Formula	C₂₇H₄₂O₄
SMILES	O.[H][C@@]12CC[C@H]([C@H](C)\C=C\[C@@H](O)C3CC3)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C
Target	Vitamin
Solubility	Ethanol:95 mg/mL (220.61 mM);DMSO:95 mg/mL (220.61 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.66 mM)

Bioactivity

−

In Vivo	The weight gain is significantly smaller in the groups treated with Diclofenac plus Calcipotriol monohydrate (p=0.018) and Diclofenac plus DFMO plus Calcipotriol monohydrate (p=0.002) compare with placebo (linear regression model). Read more...
In Vitro	Calcipotriol monohydrate (100, 10, and 1 ng/mL) significantly upregulated the expression of NKp30 on the surface of NK cells after 4 h incubation. When NHEK cells are not stimulated with IL-17A or IL-22, Calcipotriol monohydrate slightly enhances (0.2 nM) IL-8 mRNA expression or has no effect (2-20 nM). The addition of IL-17A and IL-22 markedly increased the mRNA expression of IL-8, confirming our previous study. This enhanced IL-8 mRNA expression is suppressed by Calcipotriol monohydrate (2, 20 and 40 nM) in a dose dependent manner. Read more...
Cell Research	Normal human epidermal keratinocytes are grown in serum-free keratinocyte growth medium Epilife and used at the third passage in all experiments. The growth supplement is omitted 48 h before experiments. As a control, IL-17A and IL-22 are either added or not added to the cells. Cultured NHEK cells are stimulated with IL-17A (200 ng/mL) and/or IL-22 (200 ng/mL) followed by co-incubation in the presence or absence of Calcipotriol at 0.2-40 nM to test its modulatory effect. Cells are harvested 3 days later and subjected to real-time qPCR. Culture supernatants are also collected and frozen at -80°C until used for ELISA . Read more...
Animal Research	The 160 female SKH-1 hairless mice (6-7 weeks of age) are used. After UV treatment, mice without tumors are randomly divided into five groups, four chemoprevention groups (Diclofenac plus DFMO; Diclofenac plus Calcipotriol; DFMO plus calcitriol; and Diclofenac plus DFMO plus Calcipotriol) and one placebo group (skin lotion). The mice are treated with test mixtures once a day, five days a week, for a total of 17 weeks. The test mixtures are applied topically on the dorsal surface of the mice. Ten microliters are applied by a pipette after which the mixture is rubbed onto the skin. This corresponded to the following doses of each active substance in the treatments: 100 μg/week for Diclofenac (30 mg/g undiluted), 0.166 μg/week for Calcitriol (50 μg/g undiluted), and 463.3 μg/week for DFMO (139 mg/g undiluted) . Read more...

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Calcipotriol, Calcipotriol monohydrate, Calcipotriol Monohydrate, Inhibitor, inhibit, VD/VDR, Vitamin D, Vitamin D receptor, vitamin D receptor

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

49800068 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols